Careplus Group Berhad Future Growth
Future criteria checks 0/6
Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für Careplus Group Berhad zu prognostizieren.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 20.5% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Careplus Group Berhad (KLSE:CAREPLS) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough
Feb 07
Careplus Group Berhad (KLSE:CAREPLS) Shares Fly 63% But Investors Aren't Buying For Growth
Dec 18Is Careplus Group Berhad (KLSE:CAREPLS) Using Debt Sensibly?
Nov 23Little Excitement Around Careplus Group Berhad's (KLSE:CAREPLS) Revenues
Sep 07Should You Be Adding Careplus Group Berhad (KLSE:CAREPLS) To Your Watchlist Today?
Apr 01Careplus Group Berhad (KLSE:CAREPLS) Seems To Use Debt Rather Sparingly
Feb 28Is Careplus Group Berhad (KLSE:CAREPLS) A Risky Investment?
Nov 30Is Now The Time To Put Careplus Group Berhad (KLSE:CAREPLS) On Your Watchlist?
Nov 12Does Careplus Group Berhad (KLSE:CAREPLS) Have A Healthy Balance Sheet?
May 16Investors Shouldn't Be Too Comfortable With Careplus Group Berhad's (KLSE:CAREPLS) Robust Earnings
Feb 26Could The Careplus Group Berhad (KLSE:CAREPLS) Ownership Structure Tell Us Something Useful?
Feb 13Careplus Group Berhad (KLSE:CAREPLS) Could Easily Take On More Debt
Jan 17Our View On Careplus Group Berhad's (KLSE:CAREPLS) CEO Pay
Dec 13In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Careplus Group Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2023 | 205 | -147 | -33 | -23 | N/A |
| 12/31/2022 | 262 | -122 | -103 | -58 | N/A |
| 9/30/2022 | 325 | -119 | -180 | -94 | N/A |
| 6/30/2022 | 378 | -81 | -161 | -68 | N/A |
| 3/31/2022 | 541 | 60 | -53 | 60 | N/A |
| 12/31/2021 | 700 | 221 | 58 | 181 | N/A |
| 9/30/2021 | 721 | 279 | 164 | 292 | N/A |
| 6/30/2021 | 742 | 314 | 193 | 331 | N/A |
| 3/31/2021 | 612 | 245 | 133 | 253 | N/A |
| 12/31/2020 | 476 | 122 | 50 | 149 | N/A |
| 9/30/2020 | 455 | 81 | 64 | 118 | N/A |
| 6/30/2020 | 417 | 33 | 31 | 63 | N/A |
| 3/31/2020 | 385 | -5 | 17 | 39 | N/A |
| 12/31/2019 | 365 | -6 | 33 | 48 | N/A |
| 9/30/2019 | 346 | -8 | 16 | 26 | N/A |
| 6/30/2019 | 351 | -2 | 11 | 21 | N/A |
| 3/31/2019 | 345 | -1 | 6 | 18 | N/A |
| 12/31/2018 | 339 | -1 | -1 | 14 | N/A |
| 9/30/2018 | 325 | -1 | -4 | 18 | N/A |
| 6/30/2018 | 314 | -3 | 8 | 23 | N/A |
| 3/31/2018 | 314 | -6 | 4 | 19 | N/A |
| 12/31/2017 | 323 | -2 | -1 | 13 | N/A |
| 9/30/2017 | 316 | 1 | -13 | 3 | N/A |
| 6/30/2017 | 295 | 0 | -30 | -7 | N/A |
| 3/31/2017 | 267 | 3 | N/A | -6 | N/A |
| 12/31/2016 | 229 | 0 | N/A | 4 | N/A |
| 9/30/2016 | 210 | 0 | N/A | 9 | N/A |
| 6/30/2016 | 203 | 3 | N/A | 18 | N/A |
| 3/31/2016 | 195 | 4 | N/A | 16 | N/A |
| 12/31/2015 | 190 | 6 | N/A | 18 | N/A |
| 9/30/2015 | 182 | 5 | N/A | 20 | N/A |
| 6/30/2015 | 169 | 5 | N/A | 16 | N/A |
| 3/31/2015 | 159 | 4 | N/A | 24 | N/A |
| 12/31/2014 | 152 | 3 | N/A | 20 | N/A |
| 12/31/2013 | 141 | 1 | N/A | 0 | N/A |
| 10/31/2013 | 134 | 3 | N/A | -3 | N/A |
| 7/31/2013 | 125 | 3 | N/A | -4 | N/A |
| 4/30/2013 | 114 | 4 | N/A | -8 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von CAREPLS über der Sparquote liegt (3.5%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von CAREPLS schneller wachsen werden als der Markt MY
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CAREPLS in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CAREPLS schneller wachsen werden als der Markt von MY.
Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von CAREPLS schneller wachsen werden als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CAREPLS in 3 Jahren voraussichtlich hoch sein wird